173 related articles for article (PubMed ID: 12393279)
1. Interphase fluorescence in situ hybridization detection of chromosome 17 and 17q region gains in neuroblastoma: are they secondary events?
Trakhtenbrot L; Cohen N; Betts DR; Niggli FK; Amariglio N; Brok-Simoni F; Rechavi G; Meitar D
Cancer Genet Cytogenet; 2002 Sep; 137(2):95-101. PubMed ID: 12393279
[TBL] [Abstract][Full Text] [Related]
2. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
Bown N; Lastowska M; Cotterill S; O'Neill S; Ellershaw C; Roberts P; Lewis I; Pearson AD;
Med Pediatr Oncol; 2001 Jan; 36(1):14-9. PubMed ID: 11464868
[TBL] [Abstract][Full Text] [Related]
3. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N
N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019
[TBL] [Abstract][Full Text] [Related]
4. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
[TBL] [Abstract][Full Text] [Related]
5. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
Plantaz D; Mohapatra G; Matthay KK; Pellarin M; Seeger RC; Feuerstein BG
Am J Pathol; 1997 Jan; 150(1):81-9. PubMed ID: 9006325
[TBL] [Abstract][Full Text] [Related]
6. Chromosomes that show partial loss or gain in near-diploid tumors coincide with chromosomes that show whole loss or gain in near-triploid tumors: evidence suggesting the involvement of the same genes in the tumorigenesis of high- and low-risk neuroblastomas.
Tomioka N; Kobayashi H; Kageyama H; Ohira M; Nakamura Y; Sasaki F; Todo S; Nakagawara A; Kaneko Y
Genes Chromosomes Cancer; 2003 Feb; 36(2):139-50. PubMed ID: 12508242
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes.
Van Roy N; Laureys G; Van Gele M; Opdenakker G; Miura R; van der Drift P; Chan A; Versteeg R; Speleman F
Eur J Cancer; 1997 Oct; 33(12):1974-8. PubMed ID: 9516836
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic analysis of infantile neuroblastomas by comparative genomic hybridization.
Iehara T; Hamazaki M; Sawada T
Cancer Lett; 2002 Apr; 178(1):83-9. PubMed ID: 11849745
[TBL] [Abstract][Full Text] [Related]
9. Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction.
Morowitz M; Shusterman S; Mosse Y; Hii G; Winter CL; Khazi D; Wang Q; King R; Maris JM
Mod Pathol; 2003 Dec; 16(12):1248-56. PubMed ID: 14681326
[TBL] [Abstract][Full Text] [Related]
10. Promiscuous translocations of chromosome arm 17q in human neuroblastomas.
Lastowska M; Roberts P; Pearson AD; Lewis I; Wolstenholme J; Bown N
Genes Chromosomes Cancer; 1997 Jul; 19(3):143-9. PubMed ID: 9218994
[TBL] [Abstract][Full Text] [Related]
11. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of chromosome arm 17q gain in neuroblastoma.
Janoueix-Lerosey I; Penther D; Thioux M; de Crémoux P; Derré J; Ambros P; Vielh P; Bénard J; Aurias A; Delattre O
Genes Chromosomes Cancer; 2000 Jul; 28(3):276-84. PubMed ID: 10862033
[TBL] [Abstract][Full Text] [Related]
13. der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) - detected by spectral karyotyping (SKY).
Stark B; Jeison M; Glaser-Gabay L; Bar-Am I; Mardoukh J; Ash S; Atias D; Stein J; Zaizov R; Yaniv I
Cancer Lett; 2003 Jul; 197(1-2):75-9. PubMed ID: 12880963
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines.
Lastowska M; Van Roy N; Bown N; Speleman F; Lunec J; Strachan T; Pearson AD; Jackson MS
Genes Chromosomes Cancer; 1998 Oct; 23(2):116-22. PubMed ID: 9739014
[TBL] [Abstract][Full Text] [Related]
15. Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.
Spitz R; Betts DR; Simon T; Boensch M; Oestreich J; Niggli FK; Ernestus K; Berthold F; Hero B
Cancer Genet Cytogenet; 2006 May; 167(1):51-6. PubMed ID: 16682287
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide examination of chromosomal aberrations in neuroblastoma SH-SY5Y cells by array-based comparative genomic hybridization.
Do JH; Kim IS; Park TK; Choi DK
Mol Cells; 2007 Aug; 24(1):105-12. PubMed ID: 17846504
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma.
Van Roy N; Cheng NC; Laureys G; Opdenakker G; Versteeg R; Speleman F
Eur J Cancer; 1995; 31A(4):530-5. PubMed ID: 7576960
[TBL] [Abstract][Full Text] [Related]
18. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.
Kaneko Y; Kanda N; Maseki N; Nakachi K; Takeda T; Okabe I; Sakurai M
J Clin Oncol; 1990 Dec; 8(12):2005-13. PubMed ID: 2230892
[TBL] [Abstract][Full Text] [Related]
19. Variety and complexity of chromosome 17 translocations in neuroblastoma.
Schleiermacher G; Raynal V; Janoueix-Lerosey I; Combaret V; Aurias A; Delattre O
Genes Chromosomes Cancer; 2004 Feb; 39(2):143-50. PubMed ID: 14695994
[TBL] [Abstract][Full Text] [Related]
20. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group.
Lastowska M; Cotterill S; Pearson AD; Roberts P; McGuckin A; Lewis I; Bown N
Eur J Cancer; 1997 Sep; 33(10):1627-33. PubMed ID: 9389925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
